Please join us in person at the Behavioral Health Pavilion, Room 1233, via Zoom, or via streaming link. This presentation qualifies for CME credit. To obtain your CME credit, you will need to use the U of A COM-T CloudCME system.
Update on Alzheimer's Disease
Allan Anderson, MD, MMM, DLFAPA, DFAAGP
Toole Family Memory Center
Banner Alzheimer's Institute
Associate Clinical Professor, Neurology & Psychiatry
University of Arizona College of Medicine – Tucson
Learning Objectives:
- Identify the role of new biomarkers for Alzheimer’s disease.
- Understand the clinical indications, efficacy and adverse effects for use of monoclonal antibodies in the treatment of Alzheimer’s disease.
- Appreciate the challenges in managing patients on monoclonal antibodies in the community.
The educational objective of Psychiatry Grand Rounds is to provide mental health professionals with updates on psychiatric topics with the goals of increasing knowledge, competence, and patient care. Psychiatry Grand Rounds are held on Wednesdays (September-May) from 12 to 1 p.m.
Persons with a disability may request a reasonable accommodation, such as a sign language interpreter, by contacting us at 520-874-4148. Requests should be made as early as possible to allow time to arrange the accommodation.
Accreditation Statement:
The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Arizona College of Medicine - Tucson designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Relevant Financial Relationships Statement(s):
University of Arizona College of Medicine - Tucson Office of Continuing Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.
| Name | Individual's role in activity | Nature of relationship(s) / Name of inelegible company(s) |
|---|---|---|
| Jordan F Karp, MD | Activity Director | Grant or research support-Janssen (Any division) | AdvisorAifredHealth|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Biogen (Relationship has ended)|Advisor-Otsuka America Pharmaceutical, Inc. | Advisor-Janssen (Any division) - 11/07/2024 |
| Derek Paul, MD | Planning Committee Member | Nothing to disclose - 11/01/2024 |
|
Allan Anderson, MD, MMM, DLFAPA |
Faculty |
Consulting Fee - Alphasigma (Relationship has ended) - 07/25/2025 |